Annual Total Long Term Liabilities
$158.09 M
+$4.11 M+2.67%
31 December 2023
Summary:
Century Therapeutics annual total long term liabilities is currently $158.09 million, with the most recent change of +$4.11 million (+2.67%) on 31 December 2023. During the last 3 years, it has fallen by -$42.98 million (-21.38%). IPSC annual total long term liabilities is now -21.38% below its all-time high of $201.08 million, reached on 31 December 2020.IPSC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$173.11 M
-$2.07 M-1.18%
30 September 2024
Summary:
Century Therapeutics quarterly total long term liabilities is currently $173.11 million, with the most recent change of -$2.07 million (-1.18%) on 30 September 2024. Over the past year, it has increased by +$15.22 million (+9.64%). IPSC quarterly long term liabilities is now -52.53% below its all-time high of $364.70 million, reached on 31 March 2021.IPSC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2.7% | +9.6% |
3 y3 years | -21.4% | +544.3% |
5 y5 years | - | - |
IPSC Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -21.4% | +520.4% | -1.2% | +579.4% |
5 y | 5 years | -21.4% | +520.4% | -52.5% | +579.4% |
alltime | all time | -21.4% | +520.4% | -52.5% | +579.4% |
Century Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $173.11 M(-1.2%) |
June 2024 | - | $175.18 M(+13.3%) |
Mar 2024 | - | $154.56 M(-2.2%) |
Dec 2023 | $158.09 M(+2.7%) | $158.09 M(+0.1%) |
Sept 2023 | - | $157.89 M(+5.0%) |
June 2023 | - | $150.43 M(-0.6%) |
Mar 2023 | - | $151.37 M(-1.7%) |
Dec 2022 | $153.99 M | $153.99 M(-0.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $154.64 M(+1.0%) |
June 2022 | - | $153.06 M(+8.0%) |
Mar 2022 | - | $141.67 M(+456.0%) |
Dec 2021 | $25.48 M(-87.3%) | $25.48 M(-5.2%) |
Sept 2021 | - | $26.87 M(+0.2%) |
June 2021 | - | $26.81 M(-92.6%) |
Mar 2021 | - | $364.70 M(+81.4%) |
Dec 2020 | $201.08 M(+11.9%) | $201.08 M |
Dec 2019 | $179.76 M | - |
FAQ
- What is Century Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Century Therapeutics?
- What is Century Therapeutics annual total long term liabilities year-on-year change?
- What is Century Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Century Therapeutics?
- What is Century Therapeutics quarterly long term liabilities year-on-year change?
What is Century Therapeutics annual total long term liabilities?
The current annual total long term liabilities of IPSC is $158.09 M
What is the all time high annual total long term liabilities for Century Therapeutics?
Century Therapeutics all-time high annual total long term liabilities is $201.08 M
What is Century Therapeutics annual total long term liabilities year-on-year change?
Over the past year, IPSC annual total long term liabilities has changed by +$4.11 M (+2.67%)
What is Century Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of IPSC is $173.11 M
What is the all time high quarterly long term liabilities for Century Therapeutics?
Century Therapeutics all-time high quarterly total long term liabilities is $364.70 M
What is Century Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, IPSC quarterly total long term liabilities has changed by +$15.22 M (+9.64%)